Amy E. Fraley received her BSc in Chemistry at Millersville University of Pennsylvania in 2014. She then earned her PhD in Medicinal Chemistry in 2019 from the University of Michigan College of Pharmacy working in the laboratories of Prof. David Sherman and Prof. Janet Smith where she studied fungal indole alkaloid biosynthesis and enzymology. She then moved to the ETH Zürich Institute of Microbiology for postdoctoral studies in the laboratory of Prof. Jörn Piel, with a focus on the biosynthesis of anticancer polyketides by marine symbiotic bacteria. In January 2024, she became the Assistant Professor of Medicinal Chemistry in the Institute of Pharmaceutical Sciences and the Department of Chemistry and Applied Biosciences at ETH Zürich. Inspired by the molecular complexity found in nature, her research group is developing and applying new bio-based methods for sustainable chemistry.